Medication info

Linaglipton Tablets (Linagliptin)

Prescription medicationTabletExpired
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
대우제약(주)
Appearance
Bright red, double-sided convex round film-coated tablet
Packaging
30 tablets (10 tablets/PTP packaging x 3)
Approval status
Expired

MFDS item code 201906522 · Approved 2019.09.18

This product's status changed to Expired on 2024.09.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who uses it
Adults
Adult dosage
The recommended dosage for this medication is 5 mg once daily. It can be taken regardless of meals.

Ingredients

Manufacturer
대우제약(주)

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It may be administered alone during initial treatment, and if blood sugar control is difficult with monotherapy, it can be combined with metformin. Additionally, when monotherapy with metformin or sulfonylureas is ineffective, this medication can be added to insulin therapy, or used when sulfonylureas and metformin combinations are insufficient. If blood sugar control remains inadequate with empagliflozin and metformin combination therapy, this medication can be used together to enhance therapeutic effect. Overall, this medication helps improve blood sugar control in various monotherapy or combination therapy situations.

Dosage and Administration

Adult dosage

The recommended dosage for this medication is 5 mg once daily. It can be taken regardless of meals.

Precautions

This medication should not be used in patients who have an allergic reaction to either the active ingredient or other components. It is not safe to administer this drug to patients with type 1 diabetes or diabetic ketoacidosis. When used with insulin or sulfonylureas that may induce hypoglycemia, the risk of low blood sugar may increase, requiring dose adjustment. For patients with mild to moderate heart failure, caution should be exercised during administration, and it is not recommended for severe heart failure patients. During treatment with this medication, acute pancreatitis may occur; thus, if severe abdominal pain or related symptoms arise, immediate cessation of the drug and consultation with a physician are necessary. Bullous skin conditions such as pemphigoid may occur; therefore, if blisters or dermatitis develop on the skin, medical personnel should be notified immediately, and cessation of the drug may be required if necessary. While this medication is generally safe, it can cause side effects such as hypoglycemia, gastrointestinal disturbances, and skin rashes, so consultation with a physician is advisable if symptoms occur. Use during pregnancy or lactation is discouraged, particularly during breastfeeding, which requires special caution. It is not recommended for children under 10 years of age, and careful consideration should be given to the safety and efficacy when administered to adolescents over 10 years old. Elderly patients can use it without special dose adjustments, but those with severely diminished renal or hepatic function generally do not require dose adjustments. In case of overdose, there is no specific antidote, so appropriate treatment and monitoring per symptoms are necessary. This medication should be stored out of reach of children, and it is best not to transfer it to other containers to maintain quality.

Side effects and when to seek care immediately

Serious side effects

  • Urticaria
  • angioedema
  • pancreatitis
  • pemphigoid
  • acute pancreatitis
  • acute kidney injury
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
Show 19 more
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • asthma
  • dyspnea
  • chest tightness
  • dizziness
  • severe swelling (edema)
  • severe allergic reactions
  • severe skin adverse reactions
  • kidney transplant failure
  • cerebrovascular accident
  • concussion
  • meniscus injury
  • bone fracture
  • hand fracture
  • acute pyelonephritis

Mild side effects

Hypoglycemia, nasopharyngitis, hypersensitivity, cough, constipation, oral ulcers, rash, weight gain, increased lipase levels, increased amylase levels, dyspepsia, edema, facial edema, peripheral edema, dyspepsia, increased appetite, decreased appetite, headache, drowsiness, insomnia, depression, anxiety, dizziness, paresthesia, fatigue, itching, vertigo, increased serum triglycerides, decreased hemoglobin, increased serum potassium, increased serum creatinine, increased serum creatine phosphokinase levels

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Bright red, double-sided convex round film-coated tablet

Package unit

30 tablets (10 tablets/PTP packaging x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.